Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 27% ± 5% | |
retina horizontal cell | 5 studies | 38% ± 15% | |
fibroblast | 4 studies | 21% ± 4% | |
epithelial cell | 4 studies | 27% ± 6% | |
astrocyte | 4 studies | 28% ± 12% | |
basal cell | 3 studies | 22% ± 6% | |
dendritic cell | 3 studies | 23% ± 5% | |
oligodendrocyte | 3 studies | 18% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3164.85 | 1445 / 1445 | 100% | 29.74 | 183 / 183 |
brain | 100% | 2871.83 | 2641 / 2642 | 100% | 42.62 | 705 / 705 |
prostate | 100% | 2306.89 | 245 / 245 | 100% | 25.18 | 501 / 502 |
breast | 100% | 2838.00 | 459 / 459 | 100% | 31.45 | 1114 / 1118 |
thymus | 100% | 3270.72 | 653 / 653 | 100% | 30.47 | 602 / 605 |
lung | 100% | 2074.08 | 578 / 578 | 99% | 20.44 | 1149 / 1155 |
ovary | 100% | 2440.21 | 180 / 180 | 99% | 20.47 | 427 / 430 |
liver | 100% | 2226.19 | 226 / 226 | 98% | 23.74 | 398 / 406 |
pancreas | 99% | 1278.86 | 326 / 328 | 98% | 16.11 | 175 / 178 |
bladder | 100% | 2699.14 | 21 / 21 | 97% | 18.61 | 491 / 504 |
stomach | 100% | 1611.03 | 359 / 359 | 97% | 18.33 | 277 / 286 |
uterus | 100% | 2476.25 | 170 / 170 | 97% | 20.98 | 444 / 459 |
adrenal gland | 100% | 1984.74 | 258 / 258 | 97% | 18.70 | 222 / 230 |
intestine | 100% | 2179.89 | 966 / 966 | 95% | 15.61 | 502 / 527 |
skin | 100% | 2819.32 | 1809 / 1809 | 93% | 20.24 | 441 / 472 |
kidney | 100% | 1719.79 | 89 / 89 | 92% | 16.49 | 830 / 901 |
adipose | 100% | 3079.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2555.40 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1455.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.25 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.14 | 1 / 1 |
muscle | 100% | 1353.48 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1241.53 | 825 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 13.84 | 70 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 10.36 | 24 / 29 |
peripheral blood | 31% | 705.88 | 285 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030154 | Biological process | cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003677 | Molecular function | DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZHX1 |
Protein name | Zinc fingers and homeoboxes protein 1 Zinc fingers and homeoboxes 1 |
Synonyms | |
Description | FUNCTION: Acts as a transcriptional repressor. Increases DNMT3B-mediated repressive transcriptional activity when DNMT3B is tethered to DNA. May link molecule between DNMT3B and other co-repressor proteins. . |
Accessions | Q9UKY1 ENST00000602651.1 ENST00000395571.8 [Q9UKY1-1] ENST00000522655.5 [Q9UKY1-1] ENST00000297857.3 [Q9UKY1-1] U3KPX4 |